REFERENCES
- Byar, D. P., Simon, R. M., Friedwald, W. T., Schlesselman, J. J., DeMets, D. L., Ellenberg, J. H., Gail, M. H., Ware, J. H. (1976). Randomized clinical trials—Perspectives on some recent ideas. New England Journal of Medicine 295:74–80.
- Freidlin, B., Simon, R. (2005). Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients. Clinical Cancer Research 11:7872–7878.
- Hasegawa, T., Tango, T. (2009). Permutation test following covariate-adaptive randomization in randomized controlled trials. Journal of Biopharmaceutical Statistics 19:106, 119.
- Hoering, A., LeBlanc, M., Crowley, J. J. (2008). Randomized phase III clinical trial designs for targeted agents. Clinical Cancer Research 14:4358–4367.
- Mandrekar, S. J., Sargent, D. J. (2009). Clinical trial designs for predictive biomarker validation: Theoretical considerations and practical challenges. Journal of Clinical Oncology 27:4027–4034.
- Permutt, T. (2007). A note on stratification in clinical trials. Drug Information Journal 41:719–722.
- Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., Smith, P. G. (1976). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. British Journal of Cancer 34:585–612.
- Pocock, S. J., Simon, R. (1975). Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103–115.
- Scher, H. I., Nasso, S. F., Rubin, E. H., Simon, R. (2011). Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics. Clinical Cancer Research 17:6634–6640.
- Simon, N. R., Simon, R. (2011). Using randomization tests to preserve type I error with response adaptive and covariate adaptive randomization. Statistics and Probability Letters 81:767–772.
- Simon, R., Maitournam, A. (2005). Evaluating the efficiency of targeted designs for randomized clinical trials. Clinical Cancer Research 10:6759–6763.
- Simon, R. M., Paik, S., Hayes, D. F. (2009). Use of archived specimens in evaluation of prognostic and predictive biomarkers. Journal of the National Cancer Institute 101:1446–1452.
- Simon, R. M. (2013). Genomic Clinical Trials and Predictive Medicine. New York, NY: Cambridge University Press.
- Wang, S. J., O’Neill, R. T., Hung, H. M. J. (2010). Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials. Clinical Trials 7:525–536.
- Xu, Z., Kalbfleisch, J. D. (2010). Propensity score matching in randomized clinical trials. Biometrics 66:813–823.